BIOXYTRAN, INC (72) | Uncategorized (5)
Recent Contracts
-
Approval of International Patent WO2022/099052 - Polysaccharides for Use in Treating Sars-Cov-2 Infections, dated May 12, 2022
(Filed With SEC on June 10, 2022)
-
Form of Private Placement Memorandum dated February 26, 2021
(Filed With SEC on November 17, 2021)
-
Form of Subsidiary Option dated June 4, 2021
(Filed With SEC on November 17, 2021)
-
Form of Private Placement Memorandum dated September 17, 2021
(Filed With SEC on November 17, 2021)
-
Investor Relations Agreement between Bioxytran, Inc. and Resources Unlimited NW LLC. dated April 22, 2019
(Filed With SEC on April 26, 2019)